SPG vs VXRT · rev $3.55B vs rev $66.4M
SPG (SPG) versus Vaxart Inc (VXRT) — a side-by-side from cached financials, not a winner call.
SPG (SPG) common stock.
Vaxart Inc (VXRT) is a biotechnology company listed on US.
Latest reported SPG revenue for 2026-06-30 was $3.55B. Net income was $1.14B. SPG currently screens at market cap $0.
Latest reported VXRT revenue for 2026-06-30 was $66.4M. Net income was -$8.3M. Revenue was up 69.3% from 2026-03-31 to 2026-06-30. VXRT currently screens at market cap $73.0M.
SPG currently screens at market cap $0. VXRT currently screens at market cap $73.0M.
Not investment advice. Open the SPG and VXRT stock pages for the full models.
Not investment advice.